Skip to content
Back to Guavy Wire
Crypto

Bitcoin Fuels $32M Peptide Market as Buyers Bypass Banks

Instruments
BTC
Share

The gray market for peptides is booming, with $32 million in cryptocurrency being used to purchase experimental wellness compounds in the first quarter of 2026. Bitcoin (BTC) has become a popular payment method for vendors who operate outside the prescription drug system.

Sellers are turning to crypto because banks and card networks often reject merchants selling unapproved compounds due to legal and regulatory risks. As a result, many suppliers now accept only cryptocurrency. Zach, a 49-year-old marketing director, bought 20 vials of purported retatrutide from a Chinese seller for $240, using Bitcoin through Coinbase Global Inc.

The peptide trade has expanded with demand for products marketed for weight loss and recovery. However, many suppliers operate outside the prescription drug system, shipping compounds from overseas laboratories that are often labeled as research chemicals. This has raised concerns among experts about the lack of reliable human safety and effectiveness data for these products.

More on Crypto

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc